Royalty-free stock photo ID: 1030703479
Healthcare, opioid epidemic and drug abuse concept with the map of USA filled with oxycodone and hydrocodone pharmaceutical pills on the American flag
In his 2023 State of the Union Address, then-President Joe Biden vowed, “Make no mistake: if Republicans try to raise the cost of prescription drugs, I will veto it.” Democrats cheered and applauded, while Republicans remained mostly silent.
But Republicans cheered and applauded as President Donald Trump announced on Tuesday night he would impose “major” tariffs on pharmaceuticals—prescription drugs, some life-saving, taken by nearly two out of every three Americans, including nine out of every ten seniors aged 65 or older. Over-the-counter medications like pain relievers such as Advil and Tylenol, and allergy medications, for example, could also be included.
“We’re gonna tariff our pharmaceuticals, and once we do that, they’re gonna come rushing back into our country, because we’re a big market,” Trump declared in remarks (video below) at the National Republican Congressional Committee Dinner, a black tie event for the NRCC, which works to elect Republicans to the House of Representatives.
READ MORE: Noem Slammed for Pointing Assault Rifle at Law Enforcement Officer
The contrasts were striking: one President pledging to keep prescription costs down; the other, in black tie, announcing major tariffs on medications—many of them used daily by Americans, including seniors and low-income individuals who depend on them to manage serious conditions or even to stay alive.
“The advantage we have over everybody is that we’re the big market,” President Trump went on to say, “so we’re gonna be announcing very shortly a major tariff on pharmaceuticals, and when you and when they hear that, they will leave China, they will leave other places, because they have to sell most of their product to [be] sold here, and they’re going to be opening up their plants all over the place in our country.”
According to NBC News, “Pharmaceutical imports were initially exempt from Trump’s first set of reciprocal tariffs last week,” but upon hearing the President’s announcement, global pharmaceutical manufacturers’ stocks took a tumble.
Late last month, the Brookings Institution warned that tariffs on pharmaceuticals will not provide incentive for U.S manufacturing of “off-patent generic drugs, which represent over 90% of the volume” of prescriptions dispensed. It also warned that tariffs on pharmaceuticals could lead to “product discontinuations or cost cutting that erodes quality.”
“Any production disruptions in the already fragile generic injectable markets are likely to result in shortages,” Brookings added.
Backlash to Trump’s announcement was swift, as many Americans, already under stress from the President’s massive tariff program, have seen markets in the U.S. and across the globe decimated.
Critics warn the tariffs could lead to deadly consequences
“Donald Trump wants to slap tariffs on pharmaceuticals, most of which are made outside the States, including the raw ingredients that go into almost every pill we take? That’s not being tough on China—that’s playing politics with people’s lives,” commented political strategist Shea Jordan Smith.
READ MORE: ‘Answer the Question!’: Dem Berates Trump Official Over Worst Policies ‘In My Lifetime’
“Make no mistake—this will kill Americans,” warned 314 Action, which says it is “the only organization in the nation focused on recruiting, training, and electing Democrats with a background in science to public office.” “Trump is gambling with people’s lives through his tariffs. This is why we need more doctors in Congress—to be able to stand up to Trump and protect our health care from weak spined Republicans.”
Jessica Riedl, a senior fellow at the Manhattan Institute, a conservative think tank, lamented: “President Trump wants to tax low-income families’ and seniors’ prescription drugs at accelerating rates until they can no longer afford the medications they need to survive and function. Sadistic. And Congress does nothing about it.”
Middlebury College political science professor Gary Winslett, who focuses on politics around trade and global business writes, “This has got to be one of the absolute dumbest product classes you could ever tariff.”
Robert Tyler, a senior policy advisor at a conservative European think tank, observed: “It’s one thing to disrupt global supply chains for the auto industry (because frankly people just aren’t buying that many cars at the moment anyway) but pharmaceuticals is dangerous. A lot of the world don’t have the capacity to fill a shortfall.”
Watch the video below or at this link.